July 1, 1910, the preventive medicine annex of the Research Laboratory of the New York Board of Health took over the preparation, distribution and administration of antimeningitis serum from Rockefeller Institute. Jochmann, Kolle and Wassermann, the New York Board of Health and others had prepared the serum some time before it was taken up by Rockefeller Institute, so the serum itself was not new, but the credit for introducing its intraspinal use in this country is Dr. Flexner's. Under his direction, the Rockefeller Institute prepared it and distributed it to all who would supply careful records. This was of the greatest advantage in procuring a quick decision as to its great value. During part of the last big epidemic here (1904-05) the Health Department tried using it subcutaneously and found it to be of such doubtful value that its preparation was discontinued.
Meningitis is a reportable disease in New York
DuBOIS PL, NEAL JB. SUMMARY OF FOUR YEARS OF CLINICAL AND BACTERIOLOGIC EXPERIENCE WITH MENINGITIS IN NEW YORK CITY. Am J Dis Child. 1915;IX(1):1–16. doi:10.1001/archpedi.1915.04100430004001
Pediatrics in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.